Naftidrofuryl

From Ganfyd

Jump to: navigation, search

One of the few vasodilators with evidence of net clinical effectiveness in intermittent claudication[1]. It is a selective blocker of vascular and platelet 5-hydroxytryptamine 2 (5-HT2) receptors.

Contents

Clinical Use

Indications

Administration

Oral 100 - 200mg tds in adults

Clinical Issues

Contra-indications

Cautions and Interactions

Side effects

Special advice

Pharmacology

References

This article is a work in progress. Please feel free to contribute to it.

Personal tools